Sign In
Free Newsletter
Novavax partners with Paragon, sells equipment for $18M
A Maryland biotechnology firm has sold some equipment and other assets to the Baltimore-based gene therapy unit of a New Jersey firm for roughly $18 million and both firms are planning to work together in the future.
Novavax, upbeat about progress, loses $45M in 2Q
Novavax Inc., a Gaithersburg biotech company, is pleased with its progress as it shows another quarterly loss. Novavax had a loss of $44.5 million in its second quarter, a lesser loss […]
Md. biotech sees good results from respiratory virus vaccine trial
Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. There is […]
Novavax adding up to 850 jobs in Montgomery County
A Gaithersburg-based vaccine company is planning to expand its local operations and create as many as 850 new jobs, state officials announced Wednesday. Novavax, which already has 400 full-time employees, […]
Novavax net loss up, revenue down
Novavax Inc., of Gaithersburg, a clinical-stage vaccine company, reported its net loss more than doubled and revenue dropped $2 million for the quarter ended Dec. 31. Novavax posted a net […]
Novavax loss increases
Novavax Inc., of Gaithersburg, a biopharmaceutical company focused on creating vaccines, reported higher revenues but an increased loss for the third quarter. Novavax‘s net loss was $19.7 million, or 8 […]
Novavax loss, revenue increase
Novavax Inc., of Gaithersburg, a biopharmaceutical company creating vaccines for infectious diseases worldwide, reported an increase in both revenue and net loss for the second quarter. Novavax had a net […]
Novavax rises on respiratory virus vaccine study
NEW YORK — Novavax Inc. on Tuesday reported positive results from an early clinical trial of a respiratory virus vaccine, sending its shares higher. The company is studying a vaccine […]
Rockville-based Novavax reports larger quarterly loss
Novavax Inc., of Rockville, a drug delivery company developing vaccines aimed at a broad range of infectious diseases worldwide, reported a net loss of $10 million, or 7 cents per diluted share, for the first quarter of 2013, compared to a net loss of $7.3 million, or 6 cents per share, for the year-ago period.
Rockville-based Novavax falls short of expectations
Novavax Inc., of Rockville, which is developing vaccines to treat viral infections, reported a fourth-quarter net loss of $8 million, or 6 cents per diluted share, versus a net loss of $3.7 million, or 3 cents per share, in the prior-year period.
Thomas new chair of UB real estate board
Daniel Thomas has been named chairman of the Advisory Board for the University of Baltimore, Merrick School of Business Real Estate and Economic Development Program.
In Montgomery County, a tale of two cities’ jobs
More than 400 jobs in the coveted health and biotechnology industry are coming to Gaithersburg, a huge win for the city of 60,000 residents in Montgomery County. But the jobs […]
